GlassScriptPhysician profile
Natarajan Rajan
NPI 1275598633
$1,739.52
in general payments reported to CMS, 2019-2025
13 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $88.65 · 2021: $23.93 · 2022: $94.37 · 2023: $286 · 2024: $318 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $434.77 | 2019-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $374.45 | 2019-2025 | |
| Janssen Biotech, INC. | $238.64 | 2019-2025 | Erleada |
| Pfizer INC. | $172.73 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $148.79 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $117.97 | 2019-2024 | Rezum Generator |
| Myovant Sciences INC. | $47.72 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $46.81 | 2025 | |
| Tolmar, INC. | $46.67 | 2023-2025 | Jatenzo, Eligard |
| Teleflex LLC | $42.75 | 2024-2025 | Urolift |
| Accord Healthcare, INC. | $34.32 | 2023-2024 | |
| Aytu Biopharma, INC. | $22.37 | 2019 | |
| Antares Pharma, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natarajan Rajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.